Sequent Scientific P/B Ratio
Sequent Scientific (SEQUENT) P/B ratio is 10.6 (High), book value per share ₹154.00 vs Healthcare average P/B of -0.01 — Very High - Significant premium, high growth expectations or speculative. Explore Sequent Scientific intrinsic worth to estimate fundamental worth using multiple valuation models.
Current Valuation Metrics
Book Value Breakdown (2025)
Valuation Signal
Sector Context
SEQUENT P/B Ratio — Valuation Insights & Book Value Analysis
Sequent Scientific price-to-book ratio interpretation, valuation status and historical context — current P/B 10.6 (High). Read Sequent Scientific dividend payments for the complete payout history and dividend yield track record.
- Stock appears overvalued with PB of 10.6, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 966.4% above historical average
- Trading at premium to sector average PB of -0.01
Sequent Scientific P/B Ratio Historical Trend
SEQUENT annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. For live price, earnings yield and the full fundamental profile, see Sequent Scientific share price chart.
SEQUENT Historical P/B Ratio — Book Value Per Share & Year-End Price
Sequent Scientific annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 1.35 | ₹154.0 | ₹208.54 | ₹770 | Moderate |
| 2024 | 1.23 | ₹142.6 | ₹175.86 | ₹713 | Moderate |
| 2023 | 0.76 | ₹149.8 | ₹113.75 | ₹749 | Low |
| 2022 | 0.59 | ₹148.0 | ₹87.60 | ₹740 | Low |
| 2021 | 1.04 | ₹155.2 | ₹160.95 | ₹776 | Moderate |
SEQUENT vs Healthcare Peers — P/B Ratio Comparison
Sequent Scientific P/B 10.6 vs Healthcare average -0.01, median 0.62 — range -6.55–1.09.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.0 | ₹65 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.82 | ₹129 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.21 | ₹50 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |